Parsec Financial Management, Inc. Geron Corp Transaction History
Parsec Financial Management, Inc.
- $2.37 Billion
- Q1 2023
A detailed history of Parsec Financial Management, Inc. transactions in Geron Corp stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 15,000 shares of GERN stock, worth $61,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 17,335
13.47%
Holding current value
$61,650
Previous $41,000
21.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
261Shares Held
449MCall Options Held
1.91MPut Options Held
897K-
Black Rock Inc. New York, NY46.6MShares$191 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA46.2MShares$190 Million2.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA31.9MShares$131 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$112 Million17.06% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y923.9MShares$98.3 Million12.26% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.55B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...